KCNA1 Gene Episodic ataxia type 1 Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for KCNA1 Gene Episodic ataxia type 1 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with KCNA1 Gene Episodic ataxia type 1
Test Details:
Episodic ataxia type 1 (EA1) is a rare genetic disorder that affects the nervous system, causing episodes of uncoordinated movement and muscle weakness. The KCNA1 gene is responsible for producing a protein that regulates the flow of potassium ions in nerve cells. Mutations in this gene can disrupt this process, leading to the symptoms of EA1.
NGS (Next Generation Sequencing) genetic testing is a method of analyzing DNA that allows for the detection of mutations in multiple genes simultaneously. This technology can be used to identify mutations in the KCNA1 gene that are associated with EA1.
The KCNA1 gene NGS genetic test involves collecting a sample of DNA from the patient, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations in the KCNA1 gene.
The results of the test can help diagnose EA1 and provide information about the patient’s risk of passing the condition on to their children. Genetic testing can also be used to inform treatment decisions and provide guidance for genetic counseling. However, it is important to note that not all mutations in the KCNA1 gene are associated with EA1, and a negative test result does not necessarily rule out the possibility of the condition. A comprehensive evaluation by a medical professional is recommended for anyone experiencing symptoms of EA1.
Test Name | KCNA1 Gene Episodic ataxia type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KCNA1 Gene Episodic ataxia type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNA1 Gene Episodic ataxia type 1 |
Test Details | Episodic ataxia type 1 (EA1) is a rare genetic disorder that affects the nervous system, causing episodes of uncoordinated movement and muscle weakness. The KCNA1 gene is responsible for producing a protein that regulates the flow of potassium ions in nerve cells. Mutations in this gene can disrupt this process, leading to the symptoms of EA1. NGS (Next Generation Sequencing) genetic testing is a method of analyzing DNA that allows for the detection of mutations in multiple genes simultaneously. This technology can be used to identify mutations in the KCNA1 gene that are associated with EA1. The KCNA1 gene NGS genetic test involves collecting a sample of DNA from the patient, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations in the KCNA1 gene. The results of the test can help diagnose EA1 and provide information about the patient’s risk of passing the condition on to their children. Genetic testing can also be used to inform treatment decisions and provide guidance for genetic counseling. However, it is important to note that not all mutations in the KCNA1 gene are associated with EA1, and a negative test result does not necessarily rule out the possibility of the condition. A comprehensive evaluation by a medical professional is recommended for anyone experiencing symptoms of EA1. |